How To Treat Bunions
March 29, 2013 – 12:00 am | No Comment
A bunion is a deformity that is mainly made up of a lateral deviation of the great toe which enlarges due to a tissue or a bone. It is a serious foot problem. These are formed within the foot and not on the surface of the foot. An arthritic condition and  a result of bone degeneration it is found as  a lump on the outside portion of the big toe. Bunions are seen near the joint of the toe and sometimes  [...]

Read the full story »

Home » Health News

FDA Caveats on Long-Acting Asthma Inhalers

Submitted by on February 24, 2010 – 3:48 amNo Comment



All those suffering from asthma and using long-acting beta-agonist (LABA) asthma inhalers for treating asthma signs could be facing more detrimental outcome rather than benefits.

Lately, the Food and Drug Administration (FDA) made an announcement regarding the new-fangled safety caveats mentioning that the drugs must not be employed on their own by kids or grownups. FDA states that it would need manufacturing companies include further caveats on their product labelling and requesting physicians and patients for scaling back general usage of the medications.

Director, FDA’s Center for Drug Evaluation and Research, Dr. Janet Woodcock stated that asthmatic patients must endeavour to acquire solely a solo-agent steroid inhaler medication and not be trying to obtain combination drugs along with LABA except when it is truly an urgent requirement.

FDA has pointed out that LABAs place asthmatic persons at greater chances of acute, deteriorating signs often leading to greater rates of people being hospitalized and also fatalities. The questionable LABAs are present in the single medications Serevent or Foradil and could be present in combination drugs like Symbicort, Advair that additionally comprise of inhaled corticosteroids. Corticosteroids have inflammation-suppressing and symptom allaying properties and best for asthmatics and arthritis patients. Serevent is a constituent present in Advair with Salmeterol being its active component. Symbicort contains Foradil with Formoterol as its active constituent.

The FDA has advised on limiting the lone usage of long-acting asthma medications Serevant and Foradil along with combination medications Advair and Symbicort by asthmatics due to presence of LABA that could elicit an abrupt, deadly asthmatic attack.

Though this lethal side effect is commonly noted among children, asthmatic adults have also been part of the FDA caveat. Those patients using LABAs to treat COPD or chronic obstructive pulmonary disease are not part of the newly furnished FDA warning.

The FDA ruling:
  • Warning patient on not using LABAs on their own, however merging them with other kinds of asthma controlling drugs at all times.
  • Warning asthmatics on the briefer possible usage of LABAs.
  • Limiting LABA usage to solely those asthmatics amongst whom other medications are failing to control the condition.
  • Limiting usage of Advair, Symbicort. Though asthma-controlling medications are found in such products, asthmatics must be ideally using such LABA-comprising medications for shortest time attainable.
  • Compelling LABA products to be carrying FDA caveats on their labelling.
  • Requiring LABA manufacturers to conduct further researches on the safety quotient of such medications.
  • Warning that LABA medications do not allay abrupt inception type of asthmatic attacks.
  • Instituting a novel risk management program for asthmatics among whom LABA use is needed.

Children and young patients that require a LABA alongside inhaled corticosteroids or asthma inhalers must ideally be using a combined product containing LABA as well as an inhaled corticosteroid.

The novel recommendations are applicable to solely asthma treatment and there is no ban on the single-agent LABA medications as not all asthma-controlling drugs could be merged with such inhaled drugs (asthma inhalers).

Related Posts with Thumbnails

Popularity: 1% [?]

Leave a comment!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

CommentLuv badge